Lung Organoids as Model to Study SARS-CoV-2 Infection

Area of Science:

• Virology
• Organoid Technology
• Infectious Diseases

Background:

• Coronavirus disease-2019 (COVID-19), caused by SARS-CoV-2, is a global pandemic impacting socio-economic conditions.
• The lungs are the primary organ targeted and damaged by SARS-CoV-2.
• Understanding viral mechanisms is crucial for combating COVID-19.

Purpose of the Study:

• To summarize existing lung organoid models for virological research.
• To outline human-infecting coronaviruses.
• To review studies on SARS-CoV-2 using lung organoids for pathogenesis, drug development, and precision treatment.

Main Methods:

• Literature review of lung organoids and their applications.
• Compilation of information on human coronaviruses.
• Synthesis of existing research on SARS-CoV-2 utilizing lung organoids.

Main Results:

• Human organoids serve as effective platforms for virological research and studying host-pathogen interactions.
• Lung organoids are instrumental in understanding SARS-CoV-2 pathogenesis.
• Organoids aid in the development of drugs and precision treatments for COVID-19.

Conclusions:

• Lung organoids are vital for advancing research into SARS-CoV-2 infection.
• This research highlights the potential of organoids to alleviate COVID-19-associated lung infections.
• Organoid technology offers a promising avenue for future COVID-19 research and therapeutic strategies.